I have the same mission as Benioff Children’s Hospital Oakland: to treat and improve the outcome for every child and family who comes here for care and support.
Where I see patients (2)
Selected research
-
Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease.
Blood advances
-
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial.
Lancet (London, England)
-
Hematopoietic Cell Transplant compared with Standard Care in Adolescents and Young Adults with Sickle Cell Disease.
Blood advances
Clinical trials
Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoi...
The adverse event rate will be summarized using descriptive statistics, together with 95% confidence intervals where appropriate. No formal statistical hypothesis testing will be performed. Adverse events defined: failure of engra...
Recruiting
More about this studyContact me
Learning never stops